Cargando…

Molecular Genetics Overview of Primary Mitochondrial Myopathies

Mitochondrial disorders are the most common inherited conditions, characterized by defects in oxidative phosphorylation and caused by mutations in nuclear or mitochondrial genes. Due to its high energy request, skeletal muscle is typically involved. According to the International Workshop of Experts...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arena, Ignazio Giuseppe, Pugliese, Alessia, Volta, Sara, Toscano, Antonio, Musumeci, Olimpia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836969/ https://www.ncbi.nlm.nih.gov/pubmed/35160083 http://dx.doi.org/10.3390/jcm11030632

Ejemplares similares

Primary mitochondrial myopathy: Clinical features and outcome measures in 118 cases from Italy
por: Montano, Vincenzo, et al.
Publicado: (2020)

Case Report: Thymidine Kinase 2 (TK2) Deficiency: A Novel Mutation Associated With Childhood-Onset Mitochondrial Myopathy and Atypical Progression
por: Manini, Arianna, et al.
Publicado: (2022)

Case Report: Rare Homozygous RNASEH1 Mutations Associated With Adult-Onset Mitochondrial Encephalomyopathy and Multiple Mitochondrial DNA Deletions
por: Manini, Arianna, et al.
Publicado: (2022)

Diagnostic Challenges in Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency: Clinical, Morphological, and Genetic Aspects
por: Lupica, Antonino, et al.
Publicado: (2022)

Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohort
por: Montano, V., et al.
Publicado: (2022)

Endocrine myopathies: clinical and histopathological features of the major forms
por: Rodolico, Carmelo, et al.
Publicado: (2020)

Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical Evidence
por: Camerino, Giulia Maria, et al.
Publicado: (2021)

Late and Severe Myopathy in a Patient With Glycogenosis VII Worsened by Cyclosporine and Amiodarone
por: Filosto, Massimiliano, et al.
Publicado: (2019)

Statins Neuromuscular Adverse Effects
por: Attardo, Silvia, et al.
Publicado: (2022)

S3.1 Are there ERT defined guidelines for Pompe disease?
por: Toscano, Antonio, et al.
Publicado: (2011)

S2.3 Therapeutic approaches in the late onset form of GSD II
por: Musumeci, Olimpia, et al.
Publicado: (2011)

Early is better? A new algorithm for early diagnosis in Late Onset Pompe Disease (LOPD)
por: TOSCANO, ANTONIO, et al.
Publicado: (2013)

Remarks on Mitochondrial Myopathies
por: Bottoni, Patrizia, et al.
Publicado: (2022)

Molecular genetics of human primary microcephaly: an overview
por: Faheem, Muhammad, et al.
Publicado: (2015)

Molecular Genetics of Microcephaly Primary Hereditary: An Overview
por: Siskos, Nikistratos, et al.
Publicado: (2021)

Mitochondrial Disease (MELAS Syndrome) Discovered at the Start of Pregnancy in a Patient with Advanced CKD: A Clinical and Ethical Challenge
por: Santoro, Domenico, et al.
Publicado: (2019)

Diagnosis and Treatment of Mitochondrial Myopathies
por: Ahmed, Syeda T., et al.
Publicado: (2018)

Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study
por: Camerino, Giulia M., et al.
Publicado: (2017)

Next generation sequencing on patients with LGMD and nonspecific myopathies: Findings associated with ANO5 mutations
por: Savarese, Marco, et al.
Publicado: (2015)

Diagnosis and treatment of mitochondrial myopathies
por: Pfeffer, Gerald, et al.
Publicado: (2013)

SARS-CoV-2 infection in patients with primary mitochondrial diseases: Features and outcomes in Italy
por: Mancuso, Michelangelo, et al.
Publicado: (2021)

The Role of Primary Mitochondrial Disorders in Hearing Impairment: An Overview
por: Fancello, Virginia, et al.
Publicado: (2023)

Mitochondrial dynamics: overview of molecular mechanisms
por: Tilokani, Lisa, et al.
Publicado: (2018)

Pathogenesis and treatment of mitochondrial myopathies: recent advances
por: Di Mauro, S.
Publicado: (2010)

Cardiological manifestations of mitochondrial respiratory chain disorders
por: BERARDO, A., et al.
Publicado: (2011)

Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial
por: Karaa, Amel, et al.
Publicado: (2023)

Overview of the genetic determinants of primary aldosteronism
por: Al-Salameh, Abdallah, et al.
Publicado: (2014)

Mitochondrial dysfunction in myofibrillar myopathy
por: Vincent, Amy E., et al.
Publicado: (2016)

Clevudine Induced Mitochondrial Myopathy
por: Park, Soo-Hyun, et al.
Publicado: (2017)

Educational Case: Mitochondrial Myopathy
por: Lucas, Calixto-Hope G., et al.
Publicado: (2019)

A molecular overview of the primary dystroglycanopathies
por: Brancaccio, Andrea
Publicado: (2019)

The Spectrum of Mitochondrial Ultrastructural Defects in Mitochondrial Myopathy
por: Vincent, Amy E., et al.
Publicado: (2016)

A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies
por: Musumeci, Olimpia, et al.
Publicado: (2020)

Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy
por: Karaa, Amel, et al.
Publicado: (2018)

A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
por: Karaa, Amel, et al.
Publicado: (2020)

Long-Standing Hypokalemia and Lactic Acidosis as the Primary Presentation of Mitochondrial Myopathy
por: Miao, Jing, et al.
Publicado: (2020)

An Overview of the Pathogenesis and Treatment of Elbow Osteoarthritis
por: Ravalli, Silvia, et al.
Publicado: (2019)

Interactions of mitochondrial and skeletal muscle biology in mitochondrial myopathy
por: Di Leo, Valeria, et al.
Publicado: (2023)

Entecavir: Mitochondrial myopathy: case report
Publicado: (2022)

Understanding mitochondrial myopathies: a review
por: Ahuja, Abhimanyu S.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_19a9a4tjfamchbe31k9chl6i0d